Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study

LESSONS LEARNED. Clinically applicable tools are needed for treatment selection and repurposing of available protein kinase inhibitors (PKIs) in patients with advanced solid tumors refractory to standard treatment. Using a tyrosine kinase peptide substrate microarray, observed inhibitory activity in...

Descripción completa

Detalles Bibliográficos
Autores principales: Labots, Mariette, Van der Mijn, Johannes C., Dekker, Henk, Ruijter, Rita, Pham, Thang V., Van der Vliet, Hans J., Van der Hoeven, Jacobus J.M., Meijer, Gerrit A., Verheul, Henk M.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2018
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263134/
https://www.ncbi.nlm.nih.gov/pubmed/30018133
http://dx.doi.org/10.1634/theoncologist.2018-0263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263134/
https://www.ncbi.nlm.nih.gov/pubmed/30018133
http://dx.doi.org/10.1634/theoncologist.2018-0263

Ejemplares similares